Biographical summary
Jeffrey E. Johnson, M.D., is a surgical oncologist specializing in the management of melanoma and breast cancer. He has expertise in the multimodality treatment of cancer and collaborates with colleagues across Mayo Clinic to coordinate treatment plans integrating surgery, intralesional therapy, radiation, and systemic therapies (chemotherapy, endocrine therapy, immunotherapy). He is dedicated to optimizing oncologic outcomes within a patient-centered framework. Special interests include:
- Lymph node surgery including sentinel lymph node biopsy
- Intralesional therapy for melanoma
- Metastasectomy for melanoma
- Neoadjuvant therapy for melanoma and breast cancer
- Nipple-sparing mastectomy and oncoplastic breast surgery
- Counseling and surgical management of women at high risk for breast cancer
In addition to his clinical activities, Dr. Johnson has research interests in novel therapies for locoregionally advanced melanoma, integration of machine learning in clinical practice, and patient centered outcomes and decision making in cancer care.
Conditions treated
Procedures performed
Interests
- Breast cancer surgery
- Melanoma surgery
- Sentinel lymph node surgery
- Intralesional therapies for melanoma
- Translational research
- Novel therapies and technologies
- Neoadjuvant systemic therapy
- Prophylactic mastectomy
- Nipple sparing mastectomy
Mayo Clinic locations
Education
- 2021
Fellowship - Complex General Surgical OncologyUniversity of North Carolina at Chapel Hill
- 2019
Residency - General SurgeryDepartment of Surgery, Cedars-Sinai Medical Center
- 2017
Research Fellowship - Surgical Oncology ResearchDepartment of Surgery, Cedars-Sinai Medical Center
- 2012
MDWeill Cornell Medical College
- 2007
BA - Classical Studies with HonorsWillamette University
Activities and honors
Certifications
- 2022
Complex General Surgical OncologyAmerican Board of Surgery
- 2020
General SurgeryAmerican Board of Surgery
Awards and honors
- 2023
Career Development AwardMayo Clinic
- 2018
Residents' Teaching AwardCedars-Sinai Medical Center
- 2015
Basic/Translational Research Poster Award, FinalistAnnual Symposium, Society of Surgical Oncology
- 2012
Resident Prize - Best Research PresentationNew York Chapter, American College of Surgeons
- 2007
Phi Beta KappaWillamette University
- 2007
Magna cum laudeWillamette University
Professional memberships
- 2024 - 2026
MemberSociety of Surgical Oncology, Advanced Cancer Therapies Committee
- 2023 - present
FellowAmerican College of Surgeons
- 2023 - present
Full MemberAmerican Society of Clinical Oncology
- 2023 - present
MemberMayo Clinic Cutaneous Oncology eTumor Board
- 2023 - present
MemberAmerican Medical Association
- 2023 - present
Medical EditorSubject Matter Expert - Breast Surgery & Melanoma
- 2023 - present
Preference Measurement Working Group MemberSociety for Medical Decision Making
- 2023 - present
Surgical Oncology LeadTumor Infiltrating Lymphocyte (TIL)
- 2023 - present
MemberDepartment of Surgery Innovation Committee
- 2022 - present
MemberSociety for Medical Decision Making
- 2022 - present
MemberMinnesota Surgical Society
- 2022 - present
MemberCancer Center Data Safety Monitoring Board
- 2022 - present
MemberMelanoma and Skin Cancer Disease Group
- 2022 - present
MemberBreast Disease Group
- 2021 - present
MemberMayo Clinic Breast eTumor Board
- 2021 - present
InvestigatorSP Nipple Sparing Mastectomy (NSM) Study
- 2021 - present
MemberAmerican Society of Breast Surgeons
- 2019 - present
Active StaffAmerican Board of Surgery
- 2018 - present
MemberSociety of Surgical Oncology
- 2017 - 2023
MemberAmerican College of Surgeons
Publications